FFIV vs GANX · P/E 32, rev $3.09B vs $53.0M cap
F5 Networks Inc (FFIV) versus Gain Therapeutics Inc (GANX) — a side-by-side from cached financials, not a winner call.
F5 Networks Inc (FFIV) is a software - infrastructure company listed on NASDAQ.
Gain Therapeutics Inc (GANX) is a biotechnology company listed on US.
Latest reported FFIV revenue for 2025-09-30 was $3.09B. Net income was $692.4M. FFIV currently screens at market cap $21.71B and trailing P/E 31.6.
GANX does not have a complete income-statement cache yet.
FFIV currently screens at market cap $21.71B and trailing P/E 31.6. GANX currently screens at market cap $53.0M.
Not investment advice. Open the FFIV and GANX stock pages for the full models.
Not investment advice.